Pharmaron Beijing Co., Ltd. (SHE:300759)
China · Delayed Price · Currency is CNY 28.39
-0.74 (-2.54%)
Nov 21, 2025, 3:07 PM CST
Pharmaron Beijing Market Cap
Pharmaron Beijing has a market cap or net worth of 47.49 billion as of November 21, 2025. Its market cap has decreased by -7.55% in one year.
Market Cap
47.49B
Enterprise Value
52.17B
Revenue
13.54B
Ranking
n/a
PE Ratio
33.16
Stock Price
28.39
Market Cap Chart
Since January 28, 2019, Pharmaron Beijing's market cap has increased from 7.24B to 47.49B, an increase of 556.03%. That is a compound annual growth rate of 31.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 47.49B | 13.49% |
| Dec 31, 2024 | 41.85B | -11.66% |
| Dec 29, 2023 | 47.37B | -38.44% |
| Dec 30, 2022 | 76.95B | -27.67% |
| Dec 31, 2021 | 106.40B | 12.84% |
| Dec 31, 2020 | 94.29B | 140.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 394.36B |
| WuXi AppTec | 272.52B |
| Shenzhen Mindray Bio-Medical Electronics | 235.96B |
| Sichuan Biokin Pharmaceutical | 154.69B |
| Shanghai United Imaging Healthcare | 109.47B |
| Aier Eye Hospital Group | 108.67B |
| Zhangzhou Pientzehuang Pharmaceutical., | 106.30B |
| Yunnan Baiyao Group Co.,Ltd | 99.31B |